Folium Biosciences and Nutralliance entered into a distribution partnership for Folium’s 0.0% THC broad-spectrum CBD oil products in the United States.
Photo © AdobeStock.com/Elroi
Folium Biosciences (Colorado Springs, CO), a cannabinoid manufacturer, and Nutralliance (Yorba Linda, CA), an ingredient sales and marketing company, entered into a distribution partnership for Folium’s 0.0% THC broad-spectrum CBD oil products in the United States.
“Nutralliance shares Folium’s commitment to exceptional quality,” said Folium CEO and co-founder Kashif Shan, in a press release. “That commitment coupled with their respected relationship-based approach to ingredient sales makes them the perfect partner to connect food and beverage, nutrition, animal nutrition, and cosmeceutical product manufacturers with Folium’s phytocannabinoid-rich hemp oil raw materials and white-labeled products.”
Brian Salerno, Nutralliance president and CEO, said: “The consumers our customers serve demand premium ingredients, and we’re committed to providing them with ingredient solutions that enable them to meet that growing need. Not all hemp is created equal, and Folium’s leadership in industrial hemp quality, safety and innovation is unmatched. That makes them a perfect addition to our expanding catalog of superior, science-based ingredients.
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.